Kenyon Lawrence A (CIK 0001230484)

Latest company ownership

Shares held
5,946
Last filed at
Sep 30, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 26, 2024 Sep 30, 2024 Outlook Therapeutics, Inc. CFO Buy 91.3 +5,000 528.54% ✗ $28.4K
Apr 20, 2021 Apr 20, 2021 Outlook Therapeutics, Inc. CEO Buy 91.3 +10,000 112.03% ✗ $18.3K
Sep 18, 2019 Oct 15, 2019 Outlook Therapeutics, Inc. CEO Sell 47.5 -1,350 -13.14% ✗ $2.3K
Sep 18, 2019 Sep 23, 2019 Outlook Therapeutics, Inc. CEO Sell 47.5 -1,350 -1.64% ✗ $2.3K
Feb 7, 2019 Feb 8, 2019 Outlook Therapeutics, Inc. CEO Buy 91.3 +25,000 43.70% ✗ $22.4K
Sep 18, 2018 Sep 18, 2018 Outlook Therapeutics, Inc. CEO Sell 47.5 -10,100 -15.00% ✗ $8.8K
Dec 22, 2017 Dec 26, 2017 Outlook Therapeutics, Inc. CFO Sell 46.3 -26,165 -27.99% ✗ $29.6K